| Roche hemophilia drug wins FDA nod, with a warning | | | ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra, a new medicine for hemophilia A that the Swiss drugmaker is counting on to help to offset eroding sales of older medicines going off patent. |
| |
| | |
